Literature DB >> 4813137

Tardive dyskinesia and drug therapy in geriatric patients.

G E Crane, R A Smeets.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4813137     DOI: 10.1001/archpsyc.1974.01760090055009

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


× No keyword cloud information.
  8 in total

1.  Dopamine neurochemical profile of atypical antipsychotics resembles that of D-1 antagonists.

Authors:  C A Altar; W C Boyar; A Wasley; S C Gerhardt; J M Liebman; P L Wood
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-08       Impact factor: 3.000

2.  Tardive dyskinesia and psychotropic drug history.

Authors:  G M Simpson; E Varga; J H Lee; B Zoubok
Journal:  Psychopharmacology (Berl)       Date:  1978-07-06       Impact factor: 4.530

Review 3.  Assessment of extrapyramidal disorders.

Authors:  C D Marsden; M Schachter
Journal:  Br J Clin Pharmacol       Date:  1981-02       Impact factor: 4.335

Review 4.  Management of tardive dyskinesia: current update.

Authors:  G M Simpson; E H Pi; J J Sramek
Journal:  Drugs       Date:  1982-05       Impact factor: 9.546

5.  The impact of neuroleptic medication on tardive dyskinesia: a meta-analysis of published studies.

Authors:  H Morgenstern; W M Glazer; D Niedzwiecki; P Nourjah
Journal:  Am J Public Health       Date:  1987-06       Impact factor: 9.308

6.  Prevalence of abnormal involuntary movements ("spontaneous dyskinesias") in the normal elderly.

Authors:  J M Kane; P Weinhold; B Kinon; J Wegner; M Leader
Journal:  Psychopharmacology (Berl)       Date:  1982       Impact factor: 4.530

Review 7.  Tardive dyskinesia.

Authors:  D E Casey
Journal:  West J Med       Date:  1990-11

8.  Clinical aspects of dyskinesia.

Authors:  J Ananth
Journal:  Indian J Psychiatry       Date:  1980-07       Impact factor: 1.759

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.